Oakland, CA, United States of America

Lucas Frenz

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Oakland, CA (US) (2020 - 2024)
  • San Leandro, CA (US) (2021 - 2024)

Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Lucas Frenz: Innovator in Next-Generation Sequencing Technologies

Introduction

Lucas Frenz is a prominent inventor based in Oakland, CA, who has made significant contributions to the field of biotechnology. With a total of 6 patents to his name, Frenz is recognized for his innovative approaches to sequencing technologies that enhance the accuracy and efficiency of genetic analysis.

Latest Patents

Frenz's latest patents include groundbreaking methods and compositions for deconvoluting partition barcodes. These methods assess whether multiple differently-barcoded primers occur within the same partition, which is crucial for accurate sequencing. Another notable patent focuses on synthesizing barcoding sequences utilizing phase-shift blocks. This invention provides compositions and methods for generating phase-shift barcode oligonucleotides for library construction in next-generation sequencing. In some instances, these barcode oligonucleotides are attached to particles or beads, and the patent also includes methods and kits for using these oligonucleotides in sequencing assays.

Career Highlights

Lucas Frenz is currently employed at Bio-Rad Laboratories, Inc., a leading company in the life sciences and biotechnology sector. His work at Bio-Rad has allowed him to collaborate with other talented professionals in the field, further advancing the development of innovative sequencing technologies.

Collaborations

Frenz has worked alongside notable colleagues such as Jeremy Agresti and Lung-Hsin Hung, contributing to various projects that push the boundaries of genetic research and application.

Conclusion

In summary, Lucas Frenz is a key figure in the biotechnology industry, with a focus on enhancing next-generation sequencing technologies through his innovative patents and collaborations. His work continues to impact the field significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…